GlassScriptPhysician profile
Douglas J Stanley
NPI 1023363249
$1,850.57
in general payments reported to CMS, 2019-2025
13 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $146 · 2021: $132 · 2022: $536 · 2023: $155 · 2024: $263 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $955.93 | 2019-2025 | Inspire |
| Neurent Medical Limited | $176.34 | 2022 | |
| Aerin Medical INC. | $165.57 | 2022 | |
| Integra Lifesciences Corporation | $154.14 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Tactile Systems Technology INC | $115.28 | 2019 | |
| Medtronic USA, INC. | $65.36 | 2019 | |
| Henry Schein, INC. | $62.78 | 2025 | |
| Medtronic, INC. | $51.10 | 2023-2024 | Sinuva |
| Optinose US, INC. | $29.62 | 2024 | |
| Merck Sharp & Dohme LLC | $23.93 | 2025 | Keytruda |
| Olympus America INC. | $18.10 | 2019 | |
| Acclarent, INC | $16.81 | 2019 | |
| Ethicon US, LLC | $15.61 | 2024 | Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.